PDF DatasheetInfluenza Influenza-B Tokio Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Influenza-B Tokio based upon sequence from Influenza
Host: QP12443 protein expressed in Allantonic Fluid, Allanotonic Fluid, |||.
Available Tags: Untagged
Protein Construction: A cDNA sequence encoding the sequence of Influenza-B Tokio was constructred and used to recombinantly synthesize the protein.
Recommended Applications: See Application Notes
Application Notes
Other Applications: Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA.
Bioactivity Data: Untested
Purity: Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Reconstitution Instructions: |||
Endotoxin Levels: Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
Buffer: The B/Tokio/53/99solution (1.7 mg/ml) contains STE, 0.1% sodium azide (NaN3) and 0.005% thimerosal.
Storage Conditions: B/Tokio/53/99 although stable 4°C for 4 weeks, should be stored below -18°C. Please prevent freeze-thaw cycles.
Physical Appearance: Sterile Filtered colorless solution.
Limitations and Performance Guarantee
enQuire Bio’s products are guaranteed and approved for RESEARCH USE ONLY or manufacturing purposes. This product may not be used as a pharmaceutical agent, or other product intended for human consumption without meeting additional regulatory requirements. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.
There are no reviews yet.